Advertisement
Advertisement

DBVT

DBVT logo

DBV Technologies S.A.

21.67
USD
Sponsored
-1.29
-5.60%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

21.67

0.00
-0.02%

DBVT Earnings Reports

Positive Surprise Ratio

DBVT beat 11 of 16 last estimates.

69%

Next Report

Date of Next Report
Mar 23, 2026
Estimate for Q4 25 (Revenue/ EPS)
$618.12K
/
-$0.11
Implied change from Q3 25 (Revenue/ EPS)
-77.72%
/
-54.17%
Implied change from Q4 24 (Revenue/ EPS)
--
/
--

DBV Technologies S.A. earnings per share and revenue

On Oct 28, 2025, DBVT reported earnings of -0.24 USD per share (EPS) for Q3 25, beating the estimate of -0.25 USD, resulting in a 4.95% surprise. Revenue reached 2.77 million, compared to an expected 661.55 thousand, with a 319.32% difference. The market reacted with a -2.19% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 2 analysts forecast an EPS of -0.11 USD, with revenue projected to reach 618.12 thousand USD, implying an decrease of -54.17% EPS, and decrease of -77.72% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, DBV Technologies S.A. reported EPS of -$0.24, beating estimates by 4.95%, and revenue of $2.77M, 319.32% above expectations.
The stock price moved down -2.19%, changed from $15.55 before the earnings release to $15.21 the day after.
The next earning report is scheduled for Mar 23, 2026.
Based on 2 analysts, DBV Technologies S.A. is expected to report EPS of -$0.11 and revenue of $618.12K for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement